3E0N3TZ – Introduction of Destructive Agent into Male Reproductive, Percutaneous Approach
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
PCS Table
|
Section
3
Administration
|
|||
|
Body System
E
Physiological Systems and Anatomical Regions
|
|||
|
Operation
0
Introduction
|
|||
| Body System / Region | Approach | Substance | Qualifier |
|
0
Skin and Mucous Membranes
|
X
External
|
0
Antineoplastic
|
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
0
Skin and Mucous Membranes
|
X
External
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
0
Skin and Mucous Membranes
|
X
External
|
3
Anti-inflammatory
4
Serum, Toxoid and Vaccine
B
Anesthetic Agent
K
Other Diagnostic Substance
M
Pigment
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
0
Skin and Mucous Membranes
|
X
External
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
1
Subcutaneous Tissue
|
0
Open
|
2
Anti-infective
|
A
Anti-Infective Envelope
|
|
1
Subcutaneous Tissue
|
3
Percutaneous
|
0
Antineoplastic
|
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
1
Subcutaneous Tissue
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
A
Anti-Infective Envelope
|
|
1
Subcutaneous Tissue
|
3
Percutaneous
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
1
Subcutaneous Tissue
|
3
Percutaneous
|
4
Serum, Toxoid and Vaccine
|
0
Influenza Vaccine
Z
No Qualifier
|
|
1
Subcutaneous Tissue
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
1
Subcutaneous Tissue
|
3
Percutaneous
|
V
Hormone
|
G
Insulin
J
Other Hormone
|
|
2
Muscle
|
3
Percutaneous
|
0
Antineoplastic
|
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
2
Muscle
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
2
Muscle
|
3
Percutaneous
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
2
Muscle
|
3
Percutaneous
|
4
Serum, Toxoid and Vaccine
|
0
Influenza Vaccine
Z
No Qualifier
|
|
2
Muscle
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
3
Peripheral Vein
|
0
Open
|
0
Antineoplastic
|
2
High-dose Interleukin-2
3
Low-dose Interleukin-2
5
Other Antineoplastic
M
Monoclonal Antibody
P
Clofarabine
|
|
3
Peripheral Vein
|
0
Open
|
1
Thrombolytic
|
6
Recombinant Human-activated Protein C
7
Other Thrombolytic
|
|
3
Peripheral Vein
|
0
Open
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
3
Peripheral Vein
|
0
Open
|
3
Anti-inflammatory
4
Serum, Toxoid and Vaccine
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
F
Intracirculatory Anesthetic
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
P
Platelet Inhibitor
R
Antiarrhythmic
T
Destructive Agent
X
Vasopressor
|
Z
No Qualifier
|
|
3
Peripheral Vein
|
0
Open
|
G
Other Therapeutic Substance
|
C
Other Substance
N
Blood Brain Barrier Disruption
|
|
3
Peripheral Vein
|
0
Open
|
U
Pancreatic Islet Cells
|
0
Autologous
1
Nonautologous
|
|
3
Peripheral Vein
|
0
Open
|
V
Hormone
|
G
Insulin
H
Human B-type Natriuretic Peptide
J
Other Hormone
|
|
3
Peripheral Vein
|
0
Open
|
W
Immunotherapeutic
|
K
Immunostimulator
L
Immunosuppressive
|
|
3
Peripheral Vein
|
3
Percutaneous
|
0
Antineoplastic
|
2
High-dose Interleukin-2
3
Low-dose Interleukin-2
5
Other Antineoplastic
M
Monoclonal Antibody
P
Clofarabine
|
|
3
Peripheral Vein
|
3
Percutaneous
|
1
Thrombolytic
|
6
Recombinant Human-activated Protein C
7
Other Thrombolytic
|
|
3
Peripheral Vein
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
3
Peripheral Vein
|
3
Percutaneous
|
3
Anti-inflammatory
4
Serum, Toxoid and Vaccine
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
F
Intracirculatory Anesthetic
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
P
Platelet Inhibitor
R
Antiarrhythmic
T
Destructive Agent
X
Vasopressor
|
Z
No Qualifier
|
|
3
Peripheral Vein
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
N
Blood Brain Barrier Disruption
Q
Glucarpidase
|
|
3
Peripheral Vein
|
3
Percutaneous
|
U
Pancreatic Islet Cells
|
0
Autologous
1
Nonautologous
|
|
3
Peripheral Vein
|
3
Percutaneous
|
V
Hormone
|
G
Insulin
H
Human B-type Natriuretic Peptide
J
Other Hormone
|
|
3
Peripheral Vein
|
3
Percutaneous
|
W
Immunotherapeutic
|
K
Immunostimulator
L
Immunosuppressive
|
|
4
Central Vein
|
0
Open
|
0
Antineoplastic
|
2
High-dose Interleukin-2
3
Low-dose Interleukin-2
5
Other Antineoplastic
M
Monoclonal Antibody
P
Clofarabine
|
|
4
Central Vein
|
0
Open
|
1
Thrombolytic
|
6
Recombinant Human-activated Protein C
7
Other Thrombolytic
|
|
4
Central Vein
|
0
Open
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
4
Central Vein
|
0
Open
|
3
Anti-inflammatory
4
Serum, Toxoid and Vaccine
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
F
Intracirculatory Anesthetic
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
P
Platelet Inhibitor
R
Antiarrhythmic
T
Destructive Agent
X
Vasopressor
|
Z
No Qualifier
|
|
4
Central Vein
|
0
Open
|
G
Other Therapeutic Substance
|
C
Other Substance
N
Blood Brain Barrier Disruption
|
|
4
Central Vein
|
0
Open
|
V
Hormone
|
G
Insulin
H
Human B-type Natriuretic Peptide
J
Other Hormone
|
|
4
Central Vein
|
0
Open
|
W
Immunotherapeutic
|
K
Immunostimulator
L
Immunosuppressive
|
|
4
Central Vein
|
3
Percutaneous
|
0
Antineoplastic
|
2
High-dose Interleukin-2
3
Low-dose Interleukin-2
5
Other Antineoplastic
M
Monoclonal Antibody
P
Clofarabine
|
|
4
Central Vein
|
3
Percutaneous
|
1
Thrombolytic
|
6
Recombinant Human-activated Protein C
7
Other Thrombolytic
|
|
4
Central Vein
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
4
Central Vein
|
3
Percutaneous
|
3
Anti-inflammatory
4
Serum, Toxoid and Vaccine
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
F
Intracirculatory Anesthetic
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
P
Platelet Inhibitor
R
Antiarrhythmic
T
Destructive Agent
X
Vasopressor
|
Z
No Qualifier
|
|
4
Central Vein
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
N
Blood Brain Barrier Disruption
Q
Glucarpidase
|
|
4
Central Vein
|
3
Percutaneous
|
V
Hormone
|
G
Insulin
H
Human B-type Natriuretic Peptide
J
Other Hormone
|
|
4
Central Vein
|
3
Percutaneous
|
W
Immunotherapeutic
|
K
Immunostimulator
L
Immunosuppressive
|
|
5
Peripheral Artery
6
Central Artery
|
0
Open
3
Percutaneous
|
0
Antineoplastic
|
2
High-dose Interleukin-2
3
Low-dose Interleukin-2
5
Other Antineoplastic
M
Monoclonal Antibody
P
Clofarabine
|
|
5
Peripheral Artery
6
Central Artery
|
0
Open
3
Percutaneous
|
1
Thrombolytic
|
6
Recombinant Human-activated Protein C
7
Other Thrombolytic
|
|
5
Peripheral Artery
6
Central Artery
|
0
Open
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
5
Peripheral Artery
6
Central Artery
|
0
Open
3
Percutaneous
|
3
Anti-inflammatory
4
Serum, Toxoid and Vaccine
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
F
Intracirculatory Anesthetic
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
P
Platelet Inhibitor
R
Antiarrhythmic
T
Destructive Agent
X
Vasopressor
|
Z
No Qualifier
|
|
5
Peripheral Artery
6
Central Artery
|
0
Open
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
N
Blood Brain Barrier Disruption
|
|
5
Peripheral Artery
6
Central Artery
|
0
Open
3
Percutaneous
|
V
Hormone
|
G
Insulin
H
Human B-type Natriuretic Peptide
J
Other Hormone
|
|
5
Peripheral Artery
6
Central Artery
|
0
Open
3
Percutaneous
|
W
Immunotherapeutic
|
K
Immunostimulator
L
Immunosuppressive
|
|
7
Coronary Artery
8
Heart
|
0
Open
3
Percutaneous
|
1
Thrombolytic
|
6
Recombinant Human-activated Protein C
7
Other Thrombolytic
|
|
7
Coronary Artery
8
Heart
|
0
Open
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
7
Coronary Artery
8
Heart
|
0
Open
3
Percutaneous
|
K
Other Diagnostic Substance
P
Platelet Inhibitor
|
Z
No Qualifier
|
|
7
Coronary Artery
8
Heart
|
4
Percutaneous Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
9
Nose
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
0
Antineoplastic
|
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
9
Nose
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
9
Nose
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
3
Anti-inflammatory
4
Serum, Toxoid and Vaccine
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
9
Nose
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
A
Bone Marrow
|
3
Percutaneous
|
0
Antineoplastic
|
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
A
Bone Marrow
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
B
Ear
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
B
Ear
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
B
Ear
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
3
Anti-inflammatory
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
B
Ear
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
C
Eye
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
C
Eye
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
C
Eye
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
3
Anti-inflammatory
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
M
Pigment
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
C
Eye
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
C
Eye
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
S
Gas
|
F
Other Gas
|
|
D
Mouth and Pharynx
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
D
Mouth and Pharynx
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
D
Mouth and Pharynx
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
3
Anti-inflammatory
4
Serum, Toxoid and Vaccine
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
R
Antiarrhythmic
T
Destructive Agent
|
Z
No Qualifier
|
|
D
Mouth and Pharynx
|
3
Percutaneous
7
Via Natural or Artificial Opening
X
External
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
E
Products of Conception
G
Upper GI
H
Lower GI
K
Genitourinary Tract
N
Male Reproductive
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
E
Products of Conception
G
Upper GI
H
Lower GI
K
Genitourinary Tract
N
Male Reproductive
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
E
Products of Conception
G
Upper GI
H
Lower GI
K
Genitourinary Tract
N
Male Reproductive
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
E
Products of Conception
G
Upper GI
H
Lower GI
K
Genitourinary Tract
N
Male Reproductive
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
E
Products of Conception
G
Upper GI
H
Lower GI
K
Genitourinary Tract
N
Male Reproductive
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
S
Gas
|
F
Other Gas
|
|
E
Products of Conception
G
Upper GI
H
Lower GI
K
Genitourinary Tract
N
Male Reproductive
|
4
Percutaneous Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
F
Respiratory Tract
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
F
Respiratory Tract
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
F
Respiratory Tract
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
F
Respiratory Tract
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
F
Respiratory Tract
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
S
Gas
|
D
Nitric Oxide
F
Other Gas
|
|
F
Respiratory Tract
|
4
Percutaneous Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
J
Biliary and Pancreatic Tract
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
J
Biliary and Pancreatic Tract
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
J
Biliary and Pancreatic Tract
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
J
Biliary and Pancreatic Tract
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
J
Biliary and Pancreatic Tract
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
S
Gas
|
F
Other Gas
|
|
J
Biliary and Pancreatic Tract
|
3
Percutaneous
7
Via Natural or Artificial Opening
8
Via Natural or Artificial Opening Endoscopic
|
U
Pancreatic Islet Cells
|
0
Autologous
1
Nonautologous
|
|
J
Biliary and Pancreatic Tract
|
4
Percutaneous Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
L
Pleural Cavity
|
0
Open
|
5
Adhesion Barrier
|
Z
No Qualifier
|
|
L
Pleural Cavity
|
3
Percutaneous
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
L
Pleural Cavity
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
L
Pleural Cavity
|
3
Percutaneous
|
3
Anti-inflammatory
5
Adhesion Barrier
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
L
Pleural Cavity
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
L
Pleural Cavity
|
3
Percutaneous
|
S
Gas
|
F
Other Gas
|
|
L
Pleural Cavity
|
4
Percutaneous Endoscopic
|
5
Adhesion Barrier
|
Z
No Qualifier
|
|
L
Pleural Cavity
|
4
Percutaneous Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
L
Pleural Cavity
|
7
Via Natural or Artificial Opening
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
L
Pleural Cavity
|
7
Via Natural or Artificial Opening
|
S
Gas
|
F
Other Gas
|
|
M
Peritoneal Cavity
|
0
Open
|
5
Adhesion Barrier
|
Z
No Qualifier
|
|
M
Peritoneal Cavity
|
3
Percutaneous
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
Y
Hyperthermic
|
|
M
Peritoneal Cavity
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
M
Peritoneal Cavity
|
3
Percutaneous
|
3
Anti-inflammatory
5
Adhesion Barrier
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
M
Peritoneal Cavity
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
M
Peritoneal Cavity
|
3
Percutaneous
|
S
Gas
|
F
Other Gas
|
|
M
Peritoneal Cavity
|
4
Percutaneous Endoscopic
|
5
Adhesion Barrier
|
Z
No Qualifier
|
|
M
Peritoneal Cavity
|
4
Percutaneous Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
M
Peritoneal Cavity
|
7
Via Natural or Artificial Opening
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
M
Peritoneal Cavity
|
7
Via Natural or Artificial Opening
|
S
Gas
|
F
Other Gas
|
|
P
Female Reproductive
|
0
Open
|
5
Adhesion Barrier
|
Z
No Qualifier
|
|
P
Female Reproductive
|
3
Percutaneous
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
P
Female Reproductive
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
P
Female Reproductive
|
3
Percutaneous
|
3
Anti-inflammatory
5
Adhesion Barrier
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
L
Sperm
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
V
Hormone
|
Z
No Qualifier
|
|
P
Female Reproductive
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
P
Female Reproductive
|
3
Percutaneous
|
Q
Fertilized Ovum
|
0
Autologous
1
Nonautologous
|
|
P
Female Reproductive
|
3
Percutaneous
|
S
Gas
|
F
Other Gas
|
|
P
Female Reproductive
|
4
Percutaneous Endoscopic
|
5
Adhesion Barrier
|
Z
No Qualifier
|
|
P
Female Reproductive
|
4
Percutaneous Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
P
Female Reproductive
|
7
Via Natural or Artificial Opening
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
P
Female Reproductive
|
7
Via Natural or Artificial Opening
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
P
Female Reproductive
|
7
Via Natural or Artificial Opening
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
L
Sperm
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
V
Hormone
|
Z
No Qualifier
|
|
P
Female Reproductive
|
7
Via Natural or Artificial Opening
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
P
Female Reproductive
|
7
Via Natural or Artificial Opening
|
Q
Fertilized Ovum
|
0
Autologous
1
Nonautologous
|
|
P
Female Reproductive
|
7
Via Natural or Artificial Opening
|
S
Gas
|
F
Other Gas
|
|
P
Female Reproductive
|
8
Via Natural or Artificial Opening Endoscopic
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
P
Female Reproductive
|
8
Via Natural or Artificial Opening Endoscopic
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
P
Female Reproductive
|
8
Via Natural or Artificial Opening Endoscopic
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
P
Female Reproductive
|
8
Via Natural or Artificial Opening Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
P
Female Reproductive
|
8
Via Natural or Artificial Opening Endoscopic
|
S
Gas
|
F
Other Gas
|
|
Q
Cranial Cavity and Brain
|
0
Open
3
Percutaneous
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
Q
Cranial Cavity and Brain
|
0
Open
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
Q
Cranial Cavity and Brain
|
0
Open
3
Percutaneous
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
A
Stem Cells, Embryonic
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
Q
Cranial Cavity and Brain
|
0
Open
3
Percutaneous
|
E
Stem Cells, Somatic
|
0
Autologous
1
Nonautologous
|
|
Q
Cranial Cavity and Brain
|
0
Open
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
Q
Cranial Cavity and Brain
|
0
Open
3
Percutaneous
|
S
Gas
|
F
Other Gas
|
|
Q
Cranial Cavity and Brain
|
7
Via Natural or Artificial Opening
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
Q
Cranial Cavity and Brain
|
7
Via Natural or Artificial Opening
|
S
Gas
|
F
Other Gas
|
|
R
Spinal Canal
|
0
Open
|
A
Stem Cells, Embryonic
|
Z
No Qualifier
|
|
R
Spinal Canal
|
0
Open
|
E
Stem Cells, Somatic
|
0
Autologous
1
Nonautologous
|
|
R
Spinal Canal
|
3
Percutaneous
|
0
Antineoplastic
|
2
High-dose Interleukin-2
3
Low-dose Interleukin-2
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
R
Spinal Canal
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
R
Spinal Canal
|
3
Percutaneous
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
A
Stem Cells, Embryonic
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
R
Spinal Canal
|
3
Percutaneous
|
E
Stem Cells, Somatic
|
0
Autologous
1
Nonautologous
|
|
R
Spinal Canal
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
R
Spinal Canal
|
3
Percutaneous
|
S
Gas
|
F
Other Gas
|
|
R
Spinal Canal
|
7
Via Natural or Artificial Opening
|
S
Gas
|
F
Other Gas
|
|
S
Epidural Space
|
3
Percutaneous
|
0
Antineoplastic
|
2
High-dose Interleukin-2
3
Low-dose Interleukin-2
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
S
Epidural Space
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
S
Epidural Space
|
3
Percutaneous
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
S
Epidural Space
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
S
Epidural Space
|
3
Percutaneous
|
S
Gas
|
F
Other Gas
|
|
S
Epidural Space
|
7
Via Natural or Artificial Opening
|
S
Gas
|
F
Other Gas
|
|
T
Peripheral Nerves and Plexi
X
Cranial Nerves
|
3
Percutaneous
|
3
Anti-inflammatory
B
Anesthetic Agent
T
Destructive Agent
|
Z
No Qualifier
|
|
T
Peripheral Nerves and Plexi
X
Cranial Nerves
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
U
Joints
|
0
Open
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
U
Joints
|
0
Open
|
G
Other Therapeutic Substance
|
B
Recombinant Bone Morphogenetic Protein
|
|
U
Joints
|
3
Percutaneous
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
U
Joints
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
U
Joints
|
3
Percutaneous
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
U
Joints
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
B
Recombinant Bone Morphogenetic Protein
C
Other Substance
|
|
U
Joints
|
3
Percutaneous
|
S
Gas
|
F
Other Gas
|
|
U
Joints
|
4
Percutaneous Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
V
Bones
|
0
Open
|
G
Other Therapeutic Substance
|
B
Recombinant Bone Morphogenetic Protein
|
|
V
Bones
|
3
Percutaneous
|
0
Antineoplastic
|
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
V
Bones
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
V
Bones
|
3
Percutaneous
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
V
Bones
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
B
Recombinant Bone Morphogenetic Protein
C
Other Substance
|
|
W
Lymphatics
|
3
Percutaneous
|
0
Antineoplastic
|
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
W
Lymphatics
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
W
Lymphatics
|
3
Percutaneous
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
W
Lymphatics
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
Y
Pericardial Cavity
|
3
Percutaneous
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
Y
Pericardial Cavity
|
3
Percutaneous
|
2
Anti-infective
|
8
Oxazolidinones
9
Other Anti-infective
|
|
Y
Pericardial Cavity
|
3
Percutaneous
|
3
Anti-inflammatory
6
Nutritional Substance
7
Electrolytic and Water Balance Substance
B
Anesthetic Agent
H
Radioactive Substance
K
Other Diagnostic Substance
N
Analgesics, Hypnotics, Sedatives
T
Destructive Agent
|
Z
No Qualifier
|
|
Y
Pericardial Cavity
|
3
Percutaneous
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
Y
Pericardial Cavity
|
3
Percutaneous
|
S
Gas
|
F
Other Gas
|
|
Y
Pericardial Cavity
|
4
Percutaneous Endoscopic
|
G
Other Therapeutic Substance
|
C
Other Substance
|
|
Y
Pericardial Cavity
|
7
Via Natural or Artificial Opening
|
0
Antineoplastic
|
4
Liquid Brachytherapy Radioisotope
5
Other Antineoplastic
M
Monoclonal Antibody
|
|
Y
Pericardial Cavity
|
7
Via Natural or Artificial Opening
|
S
Gas
|
F
Other Gas
|
GEM Conversion to ICD-9 PCS
Fs: 10000
–
Injection into prostate
Fs: 10000
–
Injection of therapeutic substance into testis